Nuvisan GmbH

Company

    • Company type:
      • Research & Development
      • Service Provider
    • Year founded:
    • 1979
    • Employees (at the site):
    • 267
    • Turnover range:
    • <5m EUR
    • Products/services:
    • Nuvisan's scientific and professional teams have provided best-in-class product development expertise since 1979. Our business is founded on partnership and delivery of value.
      We deliver services ranging from a single test to integrated drug development: consulting, preclinical (oncology), pharmaceutical sciences (CMC), clinical trial supplies manufacturing and distribution and Ph I-IV international clinical development.
      We focus on medical and clinical relevance from well-founded First-in-Man and Proof of Concept packages through delivery of cost and time effective dose-defining and pivotal trials, to post-registration support.
      These services are integrated through international regulatory affairs and project management and supported by state-of-the-art data systems.

    • Core competencies:
    • Pharmaceutical Development
      - Sterile & Solid Dose Manufacturing
      - Clinical Packaging & Distribution
      - Oral Drug Delivery Technologies
      - Formulation Development
      - Analytical & Stability Services
      - Microbiology Services
      Early Clinical Development
      - US and EU Phase I Sites and Bioanalytical Locations
      - Phase I-IIA Clinical Pharmacology
      - BA/BE Studies
      - Special Populations Available
      - Pharmacokinetic and PK/PD Analysis
      - Bioanalytical Services: Small and Large Molecule Capabilities
      - Full Services: Data Management, Biostatistics,Medical Writing and Regulatory Support
      Clinical Development
      - Phase I-IV Clinical Trials
      - Global Capabilities
      - Project Management
      - Clinical Monitoring
      - Data Management
      - Biostatistics
      - Medical Affairs and Safety
      - Pharmacovigilance
      - Medical and Scientific Writing

    • Language skills:
    • Afrikaans
      Croatian
      English
      French
      German
      Hungarian
      Japanese
      Russian
      Spanish
    • Key Tech / section:
      • Biotechnology: Contract research (CROs) and contract manufacturing (CMOs)
    • Industries NACE:
      • 72: Scientific research and development
    • Certification:
    • not available

    • Sales markets - target industries:
    • not available
    • Sales markets - target countries:
    • not available
    • Cooperation offers:
    • not available
    • Contact person:
    • Dr. Dietrich Bruchmann (Mr.)
      - Management

      Sylvie Bruchmann (Mrs.)
      - Sales / marketing
      - Research & development

      Karl Michaelis (Mr.)
      - Sales / marketing